NL2025628B1 - Low-intensity Focused Ultrasonic Blasting System Guided by Ultrahigh-field Magnetic Resonance - Google Patents
Low-intensity Focused Ultrasonic Blasting System Guided by Ultrahigh-field Magnetic Resonance Download PDFInfo
- Publication number
- NL2025628B1 NL2025628B1 NL2025628A NL2025628A NL2025628B1 NL 2025628 B1 NL2025628 B1 NL 2025628B1 NL 2025628 A NL2025628 A NL 2025628A NL 2025628 A NL2025628 A NL 2025628A NL 2025628 B1 NL2025628 B1 NL 2025628B1
- Authority
- NL
- Netherlands
- Prior art keywords
- magnetic resonance
- ultrasonic
- blasting
- low
- ultrasonic transducer
- Prior art date
Links
- 238000005422 blasting Methods 0.000 title abstract description 51
- 241001465754 Metazoa Species 0.000 claims abstract description 24
- 210000005036 nerve Anatomy 0.000 claims abstract description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 19
- 239000000853 adhesive Substances 0.000 claims description 3
- 238000011580 nude mouse model Methods 0.000 claims 2
- 230000005855 radiation Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 238000002595 magnetic resonance imaging Methods 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 8
- 238000003384 imaging method Methods 0.000 description 20
- 239000003814 drug Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 238000011282 treatment Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 230000010365 information processing Effects 0.000 description 4
- 239000008232 de-aerated water Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 229960003278 osimertinib Drugs 0.000 description 2
- DUYJMQONPNNFPI-UHFFFAOYSA-N osimertinib Chemical compound COC1=CC(N(C)CCN(C)C)=C(NC(=O)C=C)C=C1NC1=NC=CC(C=2C3=CC=CC=C3N(C)C=2)=N1 DUYJMQONPNNFPI-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003034 chemosensitisation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940121647 egfr inhibitor Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940121646 third-generation egfr tyrosine kinase inhibitor Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 230000006459 vascular development Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/50—Supports for surgical instruments, e.g. articulated arms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/374—NMR or MRI
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
- A61N2007/0026—Stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0056—Beam shaping elements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- High Energy & Nuclear Physics (AREA)
- Biophysics (AREA)
- Gynecology & Obstetrics (AREA)
- Surgical Instruments (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
The present invention relates to a low-intensity focused ultrasonic blasting system guided by ultrahigh-field magnetic resonance, including a 9.4 T magnetic resonance device and a low- intensity focused ultrasonic blasting device; the 9.4 T magnetic resonance device includes a main 5 magnet, a small animal bed, a magnetic resonance coil and a monitor, the low-intensity focused ultrasonic blasting device includes an ultrasonic transducer, an ultrasonic nerve stimulator and a fixing device capable of enabling the ultrasonic transducer to perform fixed-point blasting. The device provided by the present invention allows a fixed-point blasting position of an ultrasonic transducer not to be limited by an upper part of a small animal bed and a space in a magnetic 10 resonance coil, has a less interference to a magnetic resonance device, and exerts the effect of a magnetic resonance imaging device fully, thus achieving a better blasting effect.
Description
Low-intensity Focused Ultrasonic Blasting System Guided by Ultrahigh-field Magnetic Resonance
FIELD OF TECHNOLOGY The present invention belongs to the technical field of medical appliances, and relates to a focused ultrasonic blasting system and in particular to a low-intensity focused ultrasonic blasting system guided by ultrahigh-field magnetic resonance.
BACKGROUND ART Lung cancer has the highest prevalence and death rates. In recent vears, the diagnosis-treatment integrated research for tumors has drawn wide attentions. It is indicated by a great number of researches that anoxia of solid tumors 1s attributed to rapid proliferation of tumor cells and incomplete vascular development, thus causing anoxic relevant drug resistance and failures in cancer treatment. Perfluocarbon (PFC) is widely applied to inflammation imaging, cell tracking and drug release owing to its good biocompatibility and unique oxygen carrying capacity. A third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) AZD9291 drug can target T790M mutant tumors more effectively and 1s used in treatment of non-small cell lung cancers. Hence, the PFC is combined with the AZD9291 drug together to intravenously deliver to target tissues for treatment. However, the insufficient drug delivery is the main reason for treatment failures. As an effective form for energy delivery, ultrasonic waves play a huge role in ultrasonic mediated oxygen release and drug delivery. Additionally, one important application of ultrasonic waves in biology and medicine is a magnetic resonance imaging device which may obtain a magnetic resonance signal selectively by applying an appropriate gradient to a magnetic field, and processes information to obtain tissue characteristics of each point for tissue imaging. The obtained magnetic resonance image has a very high tissue resolution capability and can be very easy to distinguish normal tissues and tumor tissues, and obtain stereoscopic data within a certain volume. The magnetic resonance imaging device may image some part of a human body or even the whole body and thus is very suitable for the use of monitoring in low-intensity focused ultrasonic blasting. Presently, the research statuses and shortages of the ultrasonic blasting systems are mainly embodied in the followings: In-vivo nanoprobe molecular imaging and ultrasonic blasting processes mainly lie in: PFC drug-loading oxygen-carrying molecular imaging nanoprobes reach to target tissues via intravenous injection. and may be used for °F magnetic resonance imaging owing to its high fluorine content and good biocompatibility and stability. Then, use ultrasonic irradiation with certain energy, the PFC drug-loading oxygen-carrying molecular imaging nanoprobes are blasted at the target tissues and release the carried oxygen and drug. Monitored with 9.4 T small animal magnetic resonance, the probes achieve on-demand, accurate and quantitative controlled release, improve efficacy and action time of the drug and reduce toxicities and side effects. Meanwhile, a cavitation effect generated by microbubble blasting can accelerate blood circulation of local capillary, improve permeability of cell membranes, and promote drug uptake by the target tissues to achieve the purpose of target treatment. At last, the effect of the positioned delivery and quantitative controlled release drug is evaluated by means of technical means of a magnetic resonance instrument.
However, to achieve the purposes of blasting the PFC drug-loading oxygen-carrying molecular imaging nanoprobes in real time and monitoring the nanoprobes in real time, it is necessary to combing a magnetic resonance molecular imaging device and an ultrasonic microbubble trigger device organically and this is a key technical problem. At present, there is no special magnetic resonance mediated low-intensity focused ultrasonic device for real-time blasting and real-time imaging at home and abroad. The existing devices mainly use a current commercially-available diagnostic ultrasonic instrument for in-vitro blasting and then for magnetic resonance imaging and monitoring. Although ultrasonic irradiation, microbubble blasting and targeted release can be realized, the PFC drug-loading oxvgen-carryng molecular imaging nanoprobes cannot be blasted in real time and monitored in real time via the magnetic resonance.
SUMMARY A technical problem to be solved by the present invention is to provide, for the above shortages of the prior art, a low-intensity focused ultrasonic blasting system guided by ultrahigh-field magnetic resonance and integrated with diagnosis, blasting, monitoring and effectiveness evaluation, which is referred to as an "MR-LIFU system". The system is not limited by an upper part of a small animal bed and a space in a magnetic resonance coil, and has a less interference to a magnetic resonance device.
Technical solutions adopted to solve the technical problem of the present inventionis a low- intensity focused ultrasonic blasting system guided by ultrahigh-field magnetic resonance which includes: a 9.4 T magnetic resonance device and a low-intensity focused ultrasonic blasting device.
The 9.4 T magnetic resonance device includes a main magnet, a magnetic resonance coil, a small animal bed disposed in the magnetic resonance coil and a monitor and the small animal bed is located at a central line of the magnetic resonance device.
The low-intensity focused ultrasonic blasting device includes an ultrasonic transducer of which a diameter of a focal core in a biological focal region for focusing a tumor site is in a range of 0.1-6 mm, an ultrasonic nerve stimulator and a fixing device capable of enabling the ultrasonic transducer to perform fixed-point blasting; and the ultrasonic transducer is located at a naked-mouse tumor site of the animal bed.
In the above solutions, the ultrasonic transducer further includes a collimator device connected thereon and filled with de-aerated water.
The collimator device is located at the naked-mouse tumor site, and provided with an arched fixing device thereon; the ultrasonic transducer is fixed in the fixing device; the fixing device 1s connected to a fixing bandage capable of being fixed to the small animal bed of the magnetic resonance device, and a self-adhesive buckle capable of being bonded with each other is arranged on surfaces of two bandages. The collimator device is of a conical open structure.
The fixing device can fix the ultrasonic transducer at a tumor position of a naked mouse, and has a less interference to the magnetic resonance device to fully exert the effect of a magnetic resonance imaging device, so the ultrasonic transducer can perform an accurate fixed-point blasting operation.
Preferably, the ultrasonic transducer has a diameter of the focal core in the range of 0.1-6 mm in the biological focal regionWhen the ultrasonic transducer is manufactured, by means of controlling main parameters of the ultrasonic transducer such as a focal length and a frequency, and then verify with a focal region test and an in-vitro experiment to determine that the diameter of the focal core in the biological focal region of the ultrasonic transducer is in the range of 0.1-6 mm.
During whole blasting process, an ultrasonic transducer fixing device is independent of the small animal bed and the magnetic resonance coil, is fixed to the small animal bed via the fixing bandage, and thus greatly reduces the interference of the ultrasonic blasting device to a magnetic field of the magnetic resonance device. The present invention makes a full use of a structure and a function of the magnetic resonance device, and allows an energy applying region of the ultrasonic transducer and an imaging monitoring region of the magnetic resonance device to cross in a blasting target region, to achieve a very good blasting effect.
In the present invention, the ultrasonic transducer and the ultrasonic nerve stimulator are respectively located inside and outside a magnet. The ultrasonic transducer has a focal length of 6 mm and a diameter of 15 mm, which is matched with an acceptable range of the tumor of the naked mouse. The ultrasonic nerve stimulator has a focusing ultrasonic trigger unit that is used to output a certain energy and frequency and can allow a microbubble to blast in a targeted manner, and the energy and the frequency are respectively in a range of 0-136 W and 0.5-5 MHz. The microbubble carries oxygen and a drug. The microbubble is delivered in a focused ultrasonic positioning manner, and the microbubble is blasted in a targeted manner to release the carried oxygen and the drug.
The monitoring device includes a magnetic resonance coil. The small animal bed and the 9.4 T magnetic resonance main magnet are combined into a whole.
The present invention has the following beneficial effects: 1. the low-intensity focused ultrasonic blasting system integrated with diagnosis and treatment and mediated by the ultrahigh-field magnetic resonance merges magnetic resonance molecular imaging and ultrasonic blasting functions, realizes real-time fixed-point blasting and real-time efficacy monitoring purposes, and has a certain chemosensitization effect. 2. With the addition of a body coil, the body coil receives magnetic resonance imaging information and display a blasting site of a naked mouse, and can more accurately monitor an image in a two-dimensional scanning target region of a focal core in blasting.
The present invention is further described below in detail in combination with the embodiments and the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a structural block diagram of the present invention.
Fig. 2 is a side structural schematic diagram of the present invention.
Fig. 3 is a front structural schematic diagram of the present invention.
Fig. 4 is a structural schematic diagram of a low-intensity focused ultrasonic blasting device.
Fig. 5 is a structural schematic diagram of an ultrasonic transducer fixing device.
Fig. 6 is a top expanded structural schematic diagram of Fig. 5.
DETAILED DESCRIPTION OF THE EMBODIMENTS Referring to Figs. 1-6, names of the parts are as follows: 1-9.4 T magnetic resonance device, 2- main magnet, 3- monitor, 4-small animal bed, 5-magnetic resonance coil (body coil), 6-ultrasonic transducer, 7-ultrasonic nerve stimulator, 8-matching plate, 9-fixing device, 10-naked-mouse tumor site, 11-collimator device, 12-fixing bondage, and 13-self-adhesive buckle.
Referring to Figs. 1-6, a low-intensity focused ultrasonic blasting system guided by ultrahigh- field magnetic resonance includes: a 9.4 T magnetic resonance device 1 and a low-intensity focused ultrasonic blasting device.
The 9.4 T magnetic resonance device 1 includes a main magnet 2, a magnetic resonance coil 5, a small animal bed 4 disposed in the magnetic resonance coil 5 and a monitor 3, and the small animal bed 4 is located at a central line of the magnetic resonance device 1.
The low-intensity focused ultrasonic blasting device includes an ultrasonic transducer 6 of which a diameter of a focal core in a biological focal region for focusing a tumor site is in a range of 0.1-6 mm, an ultrasonic nerve stimulator 7 and a fixing device 9 (which allows the ultrasonic transducer 6 to be fixed on a tumor of a naked mouse) capable of enabling the ultrasonic transducer 6 to perform fixed-point blasting; and the ultrasonic transducer 6 is located at a naked-mouse tumor site 10 of the animal bed.
Referring to Fig. 2. in the magnetic resonance device, an imaging information receiving unit for receiving magnetic resonance imaging information is provided on the magnetic resonance bed, and the imaging information receiving unit is sequentially connected to an information processing unit and the monitor 3.
Referring to Fig. 4, a collimator device 11 is connected in front of the ultrasonic transducer 6.
The collimator device 11 is filled with de-aerated water. The de-aerated water serves as a medium for ultrasonic propagation and is used for cooling heat produced during ultrasonic blasting. The ultrasonic transducer 6 is located behind the collimator device 11.
The collimator device 11 is of a conical open structure. In order to reduce an influence of a movement of the blasting device to the blasting in the target region, the fixing device 9 may further be installed above the ultrasonic transducer 6. The fixing device 9 and the ultrasonic transducer 6 are jointly fixed on the small animal bed 4 (see Fig. 3).
5 The ultrasonic transducer 6 has a diameter of a focal core in a range of 0.1-6 mm in a biological focal region and a working frequency of 0.5-5 MHz. Certainly, with appropriate adjustment, a phase control transducer may also serve as a wave source for emitting an ultrasonic wave.
During blasting, a focal core focuses and blasts a target tissue, a two-dimensional imaging functional part of the 9.4 T magnetic resonance device 1 is used to monitor a two-dimensional image ma blasting process with the focal core, and the monitor 3 displays the two-dimensional image to an operator.
Referring to Fig. 3, in order to guarantee the safety in two-dimensional scanning blasting of the focal core and improve the clarity of image information collected by the magnetic resonance, the body coil 5 for receiving imaging information of the magnetic resonance device is installed at a periphery ofthe naked mouse in the small animal bed 4. The body coil 5 is fixed at the periphery of the small animal bed 4 and connected to the imaging information receiving unit of the magnetic resonance device, and is of a circular shape. As the body coil 5 receives the magnetic resonance imaging information and may display a blasting site of the naked mouse, it can more accurately monitor an image in a two-dimensional scanning target region of the focal core.
Except for the body coil 5, no change is made to the magnetic resonance imaging device. The imaging information receiving unit, the information processing unit and the monitorare all existing components of the magnetic resonance imaging device.
A working process is as follows: first of all, under the control of a control unit of a small animal bed 4, a naked mouse on the small animal bed 4 is delivered to a magnetic resonance pore, with a tumor site of the naked mouse located in a magnetic resonance imaging region; a body coil 5 is used to receive magnetic resonance imaging information and transmit the received information to an imaging information receiving unit on the magnetic resonance bed; and finally, the imaging information receiving unit transmits the information to an information processing unit for processing; and upon the processing of the information processing unit, a two-dimensional image established for a lesion in need of being blasted is displayed to an operator by a monitor 3; and then, under the control of a blasting device, a focal core of an ultrasonic transducer 6 and the lesion in the blasting target region are overlapped in a magnetic resonance volume region; and under the driving of a drive circuit (not shown in the figure), the ultrasonic transducer 6 emits an ultrasonic wave, and the focal core part is used to scan and blast the lesion in the treatment target region. As a diameter (0.1-6 mm) of the focal core is smaller than a diameter (2-5 mm) of a magnetic resonance single-layer imaging section, when a blasting process is monitored by the magnetic resonance, just need to establish the two-
dimensional image of the target, and display the established two-dimensional image to the operator via the monitor 3. In this embodiment, the focal core is used to blast the tumor site 10 of the naked mouse.
The focused intensity of the focal core is excellent in a whole biological focal region, and the energy degradation on an outer edge of the focal core is very steep and has a characteristic of a “knife”. Therefore, the low-intensity focused ultrasonic blasting system used in this embodiment may be applied to various complex blasting treatments.
Claims (4)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910696892.6A CN110507917A (en) | 2019-07-30 | 2019-07-30 | A kind of low-strength focusing ultrasonic blasting system of super high field guided by magnetic resonance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL2025628A NL2025628A (en) | 2020-07-10 |
| NL2025628B1 true NL2025628B1 (en) | 2021-07-07 |
Family
ID=68624244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL2025628A NL2025628B1 (en) | 2019-07-30 | 2020-05-20 | Low-intensity Focused Ultrasonic Blasting System Guided by Ultrahigh-field Magnetic Resonance |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN110507917A (en) |
| NL (1) | NL2025628B1 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100574829C (en) * | 2006-08-24 | 2009-12-30 | 重庆融海超声医学工程研究中心有限公司 | A kind of high-strength focus supersonic therapeutic system of image documentation equipment guiding |
| US20140066819A1 (en) * | 2012-04-13 | 2014-03-06 | Bruker Biospin Corporation | Luminescence-guided focused ultrasound apparatus and method |
| US10512794B2 (en) * | 2016-12-16 | 2019-12-24 | Brainsonix Corporation | Stereotactic frame |
| CN103230648B (en) * | 2013-04-24 | 2016-09-14 | 重庆医科大学 | Low-strength focusing ultrasonic molecular imaging and treatment system |
| JP6819012B2 (en) * | 2015-06-03 | 2021-01-27 | モンテフィオーレ メディカル センターＭｏｎｔｅｆｉｏｒｅ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ | Low-density focused ultrasound to treat cancer and metastases |
| CN106923827A (en) * | 2015-12-31 | 2017-07-07 | 中国科学院深圳先进技术研究院 | The coils special of the HIFU Treatment animal tumor guided by MRI |
| JP7237835B2 (en) * | 2016-12-15 | 2023-03-13 | ブレインソニックス コーポレイション | Treatment of degenerative dementia using a low-intensity focused ultrasound pulsation (LIFUP) device |
| CN207532377U (en) * | 2017-04-21 | 2018-06-26 | 厦门大学 | A kind of photoacoustic microscope |
-
2019
- 2019-07-30 CN CN201910696892.6A patent/CN110507917A/en active Pending
-
2020
- 2020-05-20 NL NL2025628A patent/NL2025628B1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| NL2025628A (en) | 2020-07-10 |
| CN110507917A (en) | 2019-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130102932A1 (en) | Imaging Feedback of Histotripsy Treatments with Ultrasound Transient Elastography | |
| CN104383646B (en) | Ultrasonic interventional therapy system | |
| US8224420B2 (en) | MRI guided ultrasound therapy apparatus | |
| EP2058028B1 (en) | A high intensity focused ultrasound therapeutic system guided by an imaging device guided | |
| CN101919728B (en) | Warm and hot therapeutic device | |
| JPH06254111A (en) | Ultrasonic curing device used under mri guide | |
| EP1813304B1 (en) | Apparatus for introducing a drug with ultrasounds | |
| WO2011100753A2 (en) | Interventional photoacoustic imaging system | |
| CN101119767A (en) | Method and apparatus for visualizing a focus generated using focused ultrasound | |
| CN101616712A (en) | Vltrasonic device, therapy system and the method that increases workflow | |
| KR20150120783A (en) | photoacoustic-integrated focused utrasound apparatus for diagnosis and treatment | |
| KR102148677B1 (en) | Device and method for providing ultrasound | |
| CN103028203B (en) | Ultrasonic fat reducing treatment head and method of work thereof | |
| CN105435378B (en) | A kind of focusing ultrasonic therapeutic system | |
| Damianou | In vitro and in vivo ablation of porcine renal tissues using high-intensity focused ultrasound | |
| US10271733B2 (en) | Photo-acoustic signal enhancement with microbubble-based contrast agents | |
| Zhang et al. | Real-time interleaved photoacoustic and ultrasound imaging for guiding interventional procedures | |
| NL2025628B1 (en) | Low-intensity Focused Ultrasonic Blasting System Guided by Ultrahigh-field Magnetic Resonance | |
| US20090132015A1 (en) | Method and System for Using Directional Antennas in Medical Treatments | |
| WO1999040847A2 (en) | Multi-frequency ultrasonic imaging and therapy | |
| JP4490924B2 (en) | Ultrasonic irradiation device | |
| Chua et al. | Feasibility of photoacoustic‐guided ultrasound treatment for port wine stains | |
| Simoni et al. | Ex vivo assessment of multiple parameters in high intensity focused ultrasound | |
| Liu et al. | Design and implementation of a dual-transmit/receive-mode therapeutic ultrasound phased array system for brain therapy | |
| CN116953010B (en) | Nonlinear frequency modulation ultrasonic induced magnetic resonance-photon marker fusion imaging tumor tissue optical/mechanical performance evaluation device and evaluation method |